Hy2Care (Grant)
Funding Details
Awarder
RSS - tech.eu
Date Award
May 16, 2025
Vertical
Medtech
Funding URL
View Funding Page
Funding Amount
$4,500,000
Company Info
Traction
Received FDA Investigational Device Exemption (IDE) approval to begin clinical evaluation of CartRevive in the U.S.
Market
Cartilage repair
Location
Netherlands
Coinvestors
European Innovation Council Fund, Brightlands Venture Partners, LIOF
Company Description

Hy2Care is a medtech company focused on developing CartRevive, a proprietary hydrogel implant designed to repair damaged cartilage in a minimally invasive way, offering a potential alternative to more invasive surgical treatments.

Links
Website
Back to HomeBack to Medtech DealsView Funding Announcement